Complement-Based Drug Development Summit leaderboard
  • Tuesday, September 1, 2026
  • About
  • Advertise
  • Subscribe
  • Contact

Pharma Journalist Pharma Journalist -

17th World ADC San Diego Leaderboard
  • Home
  • News
  • Drug Research
  • Clinical Trials
  • Manufacturing
  • Information Technology
  • Packaging & Labeling
  • Diseases
  • Resources
    • Articles
    • Projects
    • Case Studies
    • Industry Reports
    • Interviews
    • White Papers
  • Events
  • Press Releases
Pharma Journalist
  • Home
  • Pharma Journalist
  • Page 422

Author

Pharma Journalist 9027 posts 0 comments

LipoMedix Announces Manufacturing Agreement with ForDoz for Promitil

Feb 10, 2021
LipoMedix, a clinical-stage, oncology-focused pharmaceutical company involved in the development of innovative, safe and effective cancer therapy based on a pegylated liposomal drug…
Read More...

FDA Approves Libtayo (cemiplimab-rwlc) as First Immunotherapy Indicated for Patients with Advanced…

Feb 10, 2021
Regeneron Pharmaceuticals, Inc. and Sanofi announced that the U.S. Food and Drug Administration (FDA) approved the PD-1 inhibitor Libtayo (cemiplimab-rwlc) as the first immunotherapy…
Read More...

Pfizer and IDA Foundation Partner to Expand Access to Essential Cancer Treatments in 70 Low- and…

Feb 9, 2021
Pfizer today announced a partnership with IDA Foundation, an independent social enterprise providing essential medicines to low-and middle-income countries, to provide equitable access…
Read More...

Lilly’s bamlanivimab (LY-CoV555) administered with etesevimab (LY-CoV016) receives FDA…

Feb 9, 2021
The U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA) for investigational bamlanivimab (LY-CoV555) 700 mg and etesevimab (LY-CoV016) 1400 mg together,…
Read More...

Hangzhou Chance Pharmaceuticals Expands Pipeline with In-Licensing of AER901 from Aerami…

Feb 9, 2021
Hangzhou Chance Pharmaceuticals a clinical-stage biotechnology company focusing on discovering, developing and commercializing transformative inhalation therapies for the world’s most…
Read More...

Nuance Pharma Announces Strategic Licensing Deal with Antibe Therapeutics in China

Feb 9, 2021
Antibe Therapeutics Inc. announced that it has licensed otenaproxesul to Nuance Pharma for commercialization in the Greater China region. Nuance is a biopharmaceutical company focused…
Read More...

Registration Opens for Pre-Filled Syringes West Coast 2021

Feb 9, 2021
SMi reports: Registration is now open for the Pre-Filled Syringes West Coast, which returns as a virtual conference on 15th-16th June 2021. The highly anticipated event will explore…
Read More...

RotaChrom Technologies Partners With Cyclolab to Increase Production of COVID-19 Treatment

Feb 9, 2021
RotaChrom Technologies, the developer of the world's first industrial-scale Centrifugal Partition Chromatography (CPC) technology platform, announced the launch of a collaboration with…
Read More...

Freeline Therapeutics Updates Clinical Development Plan for its FLT180a Hemophilia B Program

Feb 8, 2021
Freeline Therapeutics Holdings plc a clinical-stage biotechnology company developing transformative adeno-associated virus vector-mediated gene therapies for patients suffering from…
Read More...

Hoth Therapeutics Partners with Camargo Pharmaceutical Services for the HT-001 IND, a Treatment for…

Feb 8, 2021
Hoth Therapeutics, Inc. a biopharmaceutical company, today announced that it has signed an agreement with Camargo Pharmaceutical Services to facilitate the writing and submission of the…
Read More...
Prev Next
Microbiome Movement USA Summit 2026
Cell Therapy for Autoimmune Disease Summit
Complement-Based Drug Development Summit
World CNS Summit South Korea
Novel CNS Biomarkers Summit Europe
8th CNS Drug Delivery Summit
Biomarker Operations & Biospecimen Management
2nd Obesity & Weight Loss Drug Development Summit Europe
RNA-Based Therapeutics & Vaccines Summit South Korea
RNA-Targeted Drug Discovery & Development Summit
mRNA Process Development & CMC Summit 2026
TPD & Induced Proximity Summit
Measuring Patient Engagement Summit Europe
Oligonucleotides Analytical Development & CMC Summit
11th CAR-TCR Summit
COPD Drug Development Summit
Neuropsychiatric Drug Development Summit
10th IPF Summit
10th Antifibrotic Drug Development Summit 2026
Model-Informed Drug Development Summit 2026
IMPACCT Real-World Evidence Summit
Raw Materials for Cell & Gene Therapy Summit
10th Dermatology Drug Development Summit
9th Lab Asset & Facility Management Summit
TRP Supply Chain & Manufacturing Summit
Covalent Drug Discovery & Development Summit
7th Genome Editing Therapeutics Summit
16th World Clinical Biomarkers & Companion Diagnostics Summit
Lipid Nanoparticles Development Summit Europe
iPSC Drug Development Summit
17th World ADC San Diego
Oligonucleotides for CNS Summit
About Us

Pharma Journalist

Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry.

Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry.

Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.

Recent Posts
  • FDA Approves Tivicay PD for Infants With HIV
  • FDA Grants Rare Pediatric Disease Designation to ReviR’s RTX-117
  • FDA Approves Ziihera Combinations for HER2-Positive GEA
  • FDA Approves RASONQUE for Metastatic Pancreatic Cancer
  • REGENXBIO Delays RGX-121 Filing After Spine MRI Findings

Industry Reports

Amgen Acquires Dark Blue to Advance Novel AML Treatments

Takeda Expands Entyvio Options Through Halozyme Technology…

Inductive Bio Wins $21M to Build AI Drug Toxicity Models

Alkermes Boosts Offer to Acquire Avadel in Deal Worth Up to…

Novartis Completes Acquisition of Tourmaline Bio to…

Press Releases

2nd T-Cell Engager for Autoimmune Disease Summit to Deliver…

2nd T-Cell Engager for Autoimmune Disease Summit Returns in…

New Era for Autoimmune T-Cell Engagers Takes Centre Stage…

From Innovation to Acquisition: CrossBridge Bio’s ADC…

COPD Foundations Joins the COPD Drug Development Summit

  • About
  • Advertise
  • Subscribe
  • Contact
© 2026 - Pharma Journalist. All Rights Reserved.
Pharma Journalist is a product of
Sign in

Welcome, Login to your account.

Forget password?
Sign in

Recover your password.

A password will be e-mailed to you.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.